Bone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationBone MarrowGraft vs Host DiseaseTransplantation ConditioningBone Marrow CellsTransplantation ChimeraTransplantation, AutologousTissue DonorsGraft SurvivalHematologic NeoplasmsHistocompatibility TestingWhole-Body IrradiationPeripheral Blood Stem Cell TransplantationLeukemiaBusulfanBone and BonesHematopoietic Stem CellsHistocompatibilityTreatment OutcomeRecurrenceAnemia, AplasticStem CellsRemission InductionGraft vs Leukemia EffectImmunosuppressive AgentsLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Tumor EffectLeukemia, Myeloid, AcuteLymphocyte DepletionMyeloablative AgonistsCombined Modality TherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte TransfusionGraft RejectionChimerismVidarabineKidney TransplantationSurvival AnalysisTime FactorsCyclophosphamideTransplantation, IsogeneicMultiple MyelomaRetrospective StudiesHLA AntigensT-LymphocytesMyelodysplastic SyndromesDisease-Free SurvivalImmunosuppressionTransplantation ImmunologyMice, Inbred C57BLCytomegalovirus InfectionsAcute DiseaseLeukocyte TransfusionHepatic Veno-Occlusive DiseaseBone Marrow PurgingRadiation ChimeraCord Blood Stem Cell TransplantationBone Marrow DiseasesSurvival RateTransplantation ToleranceMinor Histocompatibility AntigensAntilymphocyte SerumSalvage TherapyHematopoiesisMelphalanHeart TransplantationNeoplasm, ResidualSiblingsLeukemia, MyeloidAntineoplastic Combined Chemotherapy ProtocolsActuarial AnalysisGraft Enhancement, ImmunologicHematologic DiseasesBone Marrow ExaminationSkin TransplantationAntigens, CD34Follow-Up StudiesBone RemodelingCell DifferentiationHematopoietic Stem Cell MobilizationMesenchymal Stem Cell TransplantationLymphoma, Non-HodgkinVirus ActivationCell TransplantationCytarabineBone Marrow NeoplasmsFlow CytometryPrognosisPrimary MyelofibrosisLiving DonorsGranulocyte Colony-Stimulating FactorNuclear FamilyCyclosporineCytomegalovirusCells, CulturedHodgkin Disease